News in Brief
Health - Feb 26
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19
Pharmacology - Feb 26
Novartis strengthens Oncology pipeline with successful closing of tislelizumab in-licensing
Novartis strengthens Oncology pipeline with successful closing of tislelizumab in-licensing
Pharmacology - Feb 26
Novartis Cosentyx gains EU label update for first-of-its-kind MAXIMISE data in axial manifestations of psoriatic arthritis
Novartis Cosentyx gains EU label update for first-of-its-kind MAXIMISE data in axial manifestations of psoriatic arthritis
Health - Feb 26
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany
Administration - Feb 25
Federal bilateral programmes for cooperation in research and innovation with non-European partner countries 2021-2024
Federal bilateral programmes for cooperation in research and innovation with non-European partner countries 2021-2024
wire - news in brief
Category
--
Results 1 - 50 of 429.
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19
CHMP has completed a review of available data for investigational antibody cocktail casirivimab and imdevimab (REGN-COV2) to be considered for the treatment of confirmed COVID-19 CHMP scientific op
CHMP has completed a review of available data for investigational antibody cocktail casirivimab and imdevimab (REGN-COV2) to be considered for the treatment of confirmed COVID-19 CHMP scientific op
Novartis Cosentyx gains EU label update for first-of-its-kind MAXIMISE data in axial manifestations of psoriatic arthritis
Cosentyx (secukinumab) is the first biologic with proven efficacy in all 6 key manifestations of psoriatic arthritis (PsA), and the only biologic with fast and lasting relief of axial manifestations of PsA in a dedicated trial 1,2 ,3 .
Cosentyx (secukinumab) is the first biologic with proven efficacy in all 6 key manifestations of psoriatic arthritis (PsA), and the only biologic with fast and lasting relief of axial manifestations of PsA in a dedicated trial 1,2 ,3 .
A call for charging points at home
For Switzerland to become climate neutral, there's no way around electric mobility.
For Switzerland to become climate neutral, there's no way around electric mobility.
Wyss Center joins $36M international collaboration to improve recovery from spinal cord injuries
Geneva, Switzerland - The Wyss Center has joined forces with an international consortium of universities, biomedical startups and nonprofit organizations to develop therapies for spinal cord injury that could improve long-term recovery.
Geneva, Switzerland - The Wyss Center has joined forces with an international consortium of universities, biomedical startups and nonprofit organizations to develop therapies for spinal cord injury that could improve long-term recovery.
Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine
FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these infants survive without permanent ventilation and 33% sit without support, a key motor milestone not normally seen in
FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these infants survive without permanent ventilation and 33% sit without support, a key motor milestone not normally seen in
SUPSI and IRSOL enter agreement for scientific collaboration in solar research
The University of Applied Sciences and Arts of Southern Switzerland (SUPSI) and the Istituto Ricerche Solari Locarno (IRSOL, affiliated to USI) have signed a collaboration agreement that will consoli
The University of Applied Sciences and Arts of Southern Switzerland (SUPSI) and the Istituto Ricerche Solari Locarno (IRSOL, affiliated to USI) have signed a collaboration agreement that will consoli
Bloom Biorenewables develops biomass-based plastics
Thanks to technology developed by start-up Bloom Biorenewables, plant materials can be used as an alternative to petroleum derivatives for producing a wide range of products, including bioplastics, textiles, cosmetics and even perfume.
Thanks to technology developed by start-up Bloom Biorenewables, plant materials can be used as an alternative to petroleum derivatives for producing a wide range of products, including bioplastics, textiles, cosmetics and even perfume.
The Center for Data Analytics at the University of Basel helps researchers make the most of their data using cutting-edge techniques such as deep learning.
Swiss TPH and the European Chapter of the International Society of Environmental Epidemiology (ISEE) hosted a virtual symposium for young scientists in the field of environmental epidemiology from 18 to 19 February 2021.
A new simulation study shows that climate change risks significantly altering water temperature, ice cover and mixing of many Swiss lakes. Mid altitude lakes are especially under pressure, running the risk of completely losing ice cover and no longer fully mixing twice per year. Such a change would have fundamental consequences for the functioning of lake ecosystems.
The time to take low-carbon transition risks seriously is now
A successful climate policy means preparing for unintended adverse impacts, such as job losses in declining energy sectors or potential environmental impacts of scaling up renewables.
A successful climate policy means preparing for unintended adverse impacts, such as job losses in declining energy sectors or potential environmental impacts of scaling up renewables.
We need a global science panel on chemicals and waste
Chemical pollution is a global threat that demands for global action, says Zhanyun Wang. An interface body similar to the IPCC could help bridge the gap between science and policy. Chemicals are at the heart of our modern world. But the way the world deals with chemicals is highly inadequate. Over the last decades, the number and diversity of chemicals produced and traded have increased drastically, reaching several hundred thousands.
Chemical pollution is a global threat that demands for global action, says Zhanyun Wang. An interface body similar to the IPCC could help bridge the gap between science and policy. Chemicals are at the heart of our modern world. But the way the world deals with chemicals is highly inadequate. Over the last decades, the number and diversity of chemicals produced and traded have increased drastically, reaching several hundred thousands.
Scientists from the INRAE, ALLICE and UNIGE have discovered the genetic causes of the abnormal presence of an additional pair of horns in Bovids. Bovidae sometimes display supernumerary horns. For instance, local breeds of sheep genetically selected by generations of breeders, are known for their multiple horns, a condition referred to as 'polyceraty'.
Extensive remodeling of chromatin after DNA damage
In eukaryotes, histones are often modified and evicted at site of DNA double-strand breaks in order to facilitate end-resection and break repair. Together with the protein analysis facility of the FMI, the Gasser group has quantified massive changes in the chromatin associated proteome in response to DNA damage.
In eukaryotes, histones are often modified and evicted at site of DNA double-strand breaks in order to facilitate end-resection and break repair. Together with the protein analysis facility of the FMI, the Gasser group has quantified massive changes in the chromatin associated proteome in response to DNA damage.
Novartis Entresto granted expanded indication in chronic heart failure by FDA
Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined heart failure to include both those with heart failure with reduced ejection fraction (HFr
Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined heart failure to include both those with heart failure with reduced ejection fraction (HFr
Open Access @ USI: «read & publish» agreement signed with publisher Taylor & Francis
Free access to knowledge makes further progress at USI thanks to a new agreement that now allows USI researchers to publish original research articles in Open Access (OA) free of charge in journals published by Taylor & Francis, Routledge, and Cogent OA.
Free access to knowledge makes further progress at USI thanks to a new agreement that now allows USI researchers to publish original research articles in Open Access (OA) free of charge in journals published by Taylor & Francis, Routledge, and Cogent OA.
Call for transparency
The turbulence created by speculation in GameStop shares has highlighted the lack of transparency on trading platforms.
The turbulence created by speculation in GameStop shares has highlighted the lack of transparency on trading platforms.
A team from the University of Geneva and HUG managed to save a woman whose aggressive cancer left her with only five months to live.
Adult female giraffes who spend time in larger groups with other females live longer than less sociable individuals. The effects of sociability on survival outweigh other factors such as environment or human presence, a study of giraffes in Tanzania led by the University of Zurich has shown. A research team led by Monica Bond, research associate at the Department of Evolutionary Biology and Environmental Studies of the University of Zurich (UZH), studied giraffes in Tanzania for five years.
As part of the EPFL - UM6P 's Excellence in Africa initiative, the EXAF centre has announced the names of the six successful teams which will take part in the Junior Faculty Development programme (JFD).
Novartis receives FDA Breakthrough Therapy designations for investigational STAMP inhibitor asciminib (ABL001) in chronic myeloid leukemia
Designation in patients with chronic myeloid leukemia (CML) resistant or intolerant to prior treatments based on positive data from pivotal Phase III ASCEMBL trial evaluating asciminib, an investigat
Designation in patients with chronic myeloid leukemia (CML) resistant or intolerant to prior treatments based on positive data from pivotal Phase III ASCEMBL trial evaluating asciminib, an investigat
A new joint initiative from the Botnar Research Centre for Child Health and the European and Developing Countries Clinical Trials Partnership will support three COVID-19-related projects in lowand mi
Students at ETH used innovative technology to create an extremely lightweight and filigree pavilion using bamboo.
The EPFL Spacecraft Team has set itself the ambitious goal of launching two satellites by 2023. With this bold initiative, this student team hopes to gain further insight into the chemical composition of the outermost layers of our atmosphere.
A team from the University of Geneva and MSF has shown that a vial of insulin can be stored for 4 weeks after opening and at up to 37°C,without losing efficacy.
"Science Wire" gives access to latest science news from universities, research centers and R&D companies.Add this page to your bookmarks
News in Brief
Health - Feb 26
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19
Pharmacology - Feb 26
Novartis strengthens Oncology pipeline with successful closing of tislelizumab in-licensing
Novartis strengthens Oncology pipeline with successful closing of tislelizumab in-licensing
Pharmacology - Feb 26
Novartis Cosentyx gains EU label update for first-of-its-kind MAXIMISE data in axial manifestations of psoriatic arthritis
Novartis Cosentyx gains EU label update for first-of-its-kind MAXIMISE data in axial manifestations of psoriatic arthritis
Health - Feb 26
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany
Administration - Feb 25
Federal bilateral programmes for cooperation in research and innovation with non-European partner countries 2021-2024
Federal bilateral programmes for cooperation in research and innovation with non-European partner countries 2021-2024